Description
Cystoscope Devices Market size was valued at USD 610.2 billion in 2021, It is growing at a CAGR of 5.4% from 2022-28. The global market provides a detailed overview and that can be segmented by type, by application, and by end user. By type, the global cystoscope devices market has been segmented into Rigid Cystoscopes, Suprapubic cystoscopy, Flexible Cystoscopes. The Rigid Cystoscopes devices segment is likely to be the largest and fastest-growing segment in terms of type. Based on application, the global cystoscope devices market is segmented into Urinary tract infections, Kidney stones, Urinary bladder disorder, Benign prostatic hyperplasia, and chronic kidney disease. Among these, the chronic kidney disease drugs segment is expected to have the fastest-growing market during the forecast period 2022-2028 according to precision business insights. This is attributed to increasing number of end stage kidney disease’s patient number and growing demand for dialysis procedure. Based on end user, the global cystoscope devices market is segmented into Hospitals, diagnostic centers, Research Institutes. The Hospital segment accounts for the largest share in 2021 and is expected to maintain the growth in the upcoming years due to growing patient visit with urology disorders in hospital. Cystoscopy is a method that is done utilizing a particular endoscopic instrument called a cystoscope. A cystoscope is a since quite a while ago lit fibre-optic tube with a little camera toward the end, enabling the specialist to see inside your bladder and urethra, and some of the time perform strategies. A cystoscopy can uncover data that is not clear on a x-beam or ultrasound.
Key Development:
In Sept 2022, Photocure announced the commercial availability of karl storz’s new blue light system in the u.s.
In May 2020, Ambu Inc., a rapidly growing medical device maker and pioneer of sterile, single-use endoscopes, launched a new single-use cystoscope.